- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03674229
Patients Navigators in Facilitating Weight Management in Obese Participants
Using Patient Navigators to Facilitate Weight Management Among Adults
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
PRIMARY OBJECTIVES:
I. To evaluate the effectiveness of patient navigators to increase enrollment in evidence-based weight management programs.
SECONDARY OBJECTIVES:
I. To evaluate the effectiveness of patient navigators to increase overall attendance or use of evidence-based weight management programs.
II. To evaluate the effectiveness of patient navigators to promoting and facilitating positive health behavior change: increased physical activity; improved diet; and weight loss.
OUTLINE: Participants are randomized to 1 of 2 groups.
GROUP I: Participants receive information about commercially-available weight management programs and encouragement to participate in one of the programs for 6 months.
GROUP II: Participants receive information about commercially-available weight management programs encouragement to participate in one of the programs for 6 months. Participants also receive 6 phone calls over 20-30 minutes each from an assigned patient navigator for 6 months.
After completion of the study, participants are followed up at 2 months.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- M D Anderson Cancer Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Are referred by a University of Texas (UT) health care provider
- Have a body mass index (BMI) greater than or equal to 30 and less than or equal to 45 kg/m^2
- Are able to read and speak English
- Have a working telephone number and address where materials can be mailed
- Able to engage in moderate intensity physical activity as determined by the Physical Activity Readiness Questionnaire (PAR-Q)
- Internet access at home or other location (e.g., work, church, library, community center, etc.)
Exclusion Criteria:
- Another person in the same household already enrolled in the proposed intervention
- Pregnant or thinking about becoming pregnant during the study period
- Are already involved in another weight loss program
- Participated in a weight loss, exercise, or dietary modification program in the previous 6 months
- Involuntary or voluntary weight loss of greater than or equal to 5% body weight in the previous 6 months
- Are currently using weight loss medications
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Group I (information about weight management programs)
Participants receive information about commercially-available weight management programs and encouragement to participate in one of the programs for 6 months.
|
Ancillary studies
Receive information about weight management programs
|
Experimental: Group II (information, call from patient navigator)
Participants receive information about commercially-available weight management programs encouragement to participate in one of the programs for 6 months.
Participants also receive 6 phone calls over 20-30 minutes each from an assigned patient navigator for 6 months.
|
Ancillary studies
Receive information about weight management programs
Receive phone calls from an assigned patient navigator
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in participant enrollment in evidence-based weight management programs
Time Frame: Up to 6 months
|
We will compare differences in the proportion of self-reported enrollment in any program between intervention and control groups.
|
Up to 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Participant attendance or use of evidence-based weight management programs
Time Frame: Up to 6 months
|
Attendance is a continuous variable and is defined as the total number of self-reported sessions attended or used by each participant.
|
Up to 6 months
|
Positive change in physical activity
Time Frame: Baseline up to 6 months
|
Accelerometer data will provide an objective assessment of physical activity (PA) We will calculate minutes of PA per week and meeting recommendations (yes/no).
|
Baseline up to 6 months
|
Measurement of fruit and vegetable consumption
Time Frame: Baseline up to 6 months
|
Fruit and vegetable consumption (i.e., # servings per day) will be measured using the 24 hour recall.
Finally, objective measure of weight will be captured at each data collection time point.
|
Baseline up to 6 months
|
Objectively measured weight change.
Time Frame: Baseline up to 6 months
|
Change in body weight from baseline will be calculated.
|
Baseline up to 6 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Lorna McNeill, M.D. Anderson Cancer Center
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2015-0255 (Other Identifier: M D Anderson Cancer Center)
- P30CA016672 (U.S. NIH Grant/Contract)
- UL1TR000371 (U.S. NIH Grant/Contract)
- NCI-2018-01819 (Registry Identifier: CTRP (Clinical Trial Reporting Program))
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuNot yet recruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on Questionnaire Administration
-
Fondazione Don Carlo Gnocchi OnlusUnknown
-
Centre Oscar LambretCentre Hospitalier Universitaire de BesanconTerminated
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)TerminatedHealth Status UnknownUnited States
-
Istanbul Aydın UniversityCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingBreast Carcinoma | Fallopian Tube Carcinoma | Endometrial Carcinoma | Ovarian Carcinoma | Primary Peritoneal Carcinoma | Deleterious CDH1 Gene Mutation | Deleterious DICER1 Gene Mutation | Deleterious SMARCA4 Gene Mutation | Deleterious STK11 Gene MutationUnited States
-
Hospital Clínico Universitario de ValladolidRed Centinela Sanitaria de Castilla y León (RCSCYL); Centro Nacional de Gripe... and other collaboratorsRecruitingMigraine | Headache Disorders | Viral Infection | Influenza -Like Illness | Head PainSpain
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingBreast Ductal Carcinoma In Situ | Invasive Breast Carcinoma | COVID-19 Infection | Hereditary Breast CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Recurrent Lymphoma | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Recurrent Plasma Cell Myeloma | Caregiver | Recurrent LeukemiaUnited States
-
I.M. Sechenov First Moscow State Medical UniversityAgency of Social Information St. PetersburgActive, not recruiting
-
I.M. Sechenov First Moscow State Medical UniversityActive, not recruitingShoulder ArthropathyRussian Federation